Tomer Kariv, Director at Eloxx Pharmaceuticals, Inc. (ELOX), bought 200,000 shares at $9.00 ($1.8M) on 2019-06-24, disclosed to the SEC on 2019-06-26.
Open-market purchase of $1.8M ELOX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.00 | 24,000 | $216K | 12.0% |
| 2 | $9.00 | 42,261 | $380K | 21.1% |
| 3 | $9.00 | 46,933 | $422K | 23.5% |
| 4 | $9.00 | 86,806 | $781K | 43.4% |
| Total | $9.00 avg | 200,000 | $1.8M | 100% |
| Filing → |
| VBIV | BUY | 2018-12-18 | $4.0M | — | Filing → |
| LOGC | BUY | 2018-10-25 | $4.2M | — | Filing → |
| ELOX | BUY | 2018-05-01 | $6.8M | — | Filing → |